Summary
Latest filing:
Kevin Michael Coveney is Chief Financial Officer of Enveric Biosciences, Inc. (ENVB). 3 SEC Form 4 filings on record going back to 2024, most recently on 3 June 2026.
Recent Transactions
3Every recent SEC Form 4 transaction Kevin Michael Coveney has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Kevin Michael Coveney's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Fairmount Funds Management LLC - $300.01M of ORKA open-market activity in the last 12 months
- A/S Genmab - $234.86M of MRUS open-market activity in the last 12 months
- Weiss Asset Management LP - $233.35M of AVDL open-market activity in the last 12 months
- August J. Troendle - $232.59M of MEDP open-market activity in the last 12 months
- James Edgemond - $201.52M of UTHR open-market activity in the last 12 months
- Scilex Holding Co - $200.00M of SMNR open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Kevin Michael Coveney?
Kevin Michael Coveney is a corporate insider, tracked as Chief Financial Officer of Enveric Biosciences, Inc. (ENVB). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Kevin Michael Coveney last file a Form 4?
The most recent primary Form 4 on record is dated 3 June 2026, one of 3 filings going back to 2024.
Where can I see all of Kevin Michael Coveney's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Kevin Michael Coveney and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
